Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Growth hormone deficiency


See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment


Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Growth hormone deficiency. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Somatropin
Trade Name
(Manufacturer Name)
Genotropin®
(Pfizer)
Indication
The FDA has approved this product to be used in this manner.
Treatment of adults with growth hormone deficiency.
More Information about this product Drug Information Portal

Generic Name Sermorelin acetate
Trade Name
(Manufacturer Name)
Geref
(EMD Serono, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of idiopathic or organic growth hormone deficiency in children with growth failure.
More Information about this product Drug Information Portal

Generic Name Somatropin (r-DNA) for injection
Trade Name
(Manufacturer Name)
Humatrope®
(Eli Lilly and Company)
Indication
The FDA has approved this product to be used in this manner.
For the long-term treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone.
More Information about this product Drug Information Portal

Generic Name Somatropin (r-DNA) for injection
Trade Name
(Manufacturer Name)
Norditropin®
(Novo Nordisk Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Long-term treatment of children who have growth failure due to inadequate secretion of endogenous growth hormone.
More Information about this product Drug Information Portal

Generic Name Somatropin
Trade Name
(Manufacturer Name)
Nutropin®
(Genentech, Inc.)
Indication
The FDA has approved this product to be used in this manner.
For use in the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.
More Information about this product Drug Information Portal

Generic Name Somatropin (rDNA origin)
Trade Name
(Manufacturer Name)
Nutropin®
(Genentech, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Long-term treatment of growth failure due to a lack of adequate endogenous growth hormone secetion for once- or twice-a-month administration.
More Information about this product Drug Information Portal

Generic Name Somatropin (r-DNA) for injection
Trade Name
(Manufacturer Name)
Nutropin®
(Genentech, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of children with growth failure associated with chronic renal insufficency.
More Information about this product Drug Information Portal

Generic Name Somatrem for injection
Trade Name
(Manufacturer Name)
Protropin
(Genentech, Inc.)
Indication
The FDA has approved this product to be used in this manner.
For long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion.
More Information about this product Drug Information Portal

Generic Name Somatropin (rDNA origin)
Trade Name
(Manufacturer Name)
Saizen®
(EMD Serono, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Long term treatment of children with growth failure due to inadequate secretion of endogenous growth hormone.
More Information about this product Drug Information Portal